These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Angiographic trials of lipid-lowering therapy: end of an era? Thompson GR Br Heart J; 1995 Oct; 74(4):343-7. PubMed ID: 7488443 [No Abstract] [Full Text] [Related]
27. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation. Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811 [TBL] [Abstract][Full Text] [Related]
28. Lovastatin versus pravastatin for hypercholesterolemia. Goldstein MR Am J Cardiol; 1994 Feb; 73(5):416; author reply 417-8. PubMed ID: 8109563 [No Abstract] [Full Text] [Related]
29. Effect of bezafibrate or pravastatin on serum lipid levels and albuminuria in NIDDM patients. Nagai T; Tomizawa T; Nakajima K; Mori M J Atheroscler Thromb; 2000; 7(2):91-6. PubMed ID: 11426588 [TBL] [Abstract][Full Text] [Related]
30. [A case of possible lovastatin-induced pancreatitis in concomitant Gilbert syndrome]. Pluhar W Wien Klin Wochenschr; 1989 Sep; 101(16):551-4. PubMed ID: 2800552 [TBL] [Abstract][Full Text] [Related]
31. Comparative and simultaneous effects of simvastatin and ciprofibrate on plasma lipid parameters and upon hepatic drug metabolizing and peroxisome proliferation marker enzymes in the male Wistar rat. Charmoillaux M; Goudonnet H; Mercenne F; Mounié J; Truchot RC Cell Mol Biol; 1991; 37(8):765-71. PubMed ID: 1807786 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of dyslipidemia of the elderly with simvastatin and pravastatin. Effectiveness and tolerance]. Panuccio D; Trabatti MR; Romani A Clin Ter; 1994 May; 144(5):419-24. PubMed ID: 7924180 [TBL] [Abstract][Full Text] [Related]
33. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia. Smith DH; Neutel JM; Jankelow D; Myburgh DP S Afr Med J; 1990 May; 77(10):500-3. PubMed ID: 2188379 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins. Richter WO; Jacob BG; Schwandt P Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291 [TBL] [Abstract][Full Text] [Related]
35. Bezafibrate and simvastatin: different beneficial effects for different therapeutic aims. Tenenbaum A; Fisman EZ; Motro M J Clin Endocrinol Metab; 2004 Apr; 89(4):1978; author reply 1978-9. PubMed ID: 15070976 [No Abstract] [Full Text] [Related]
36. Hypercholesterolemia treatment in a renal transplant patient. Devuyst O; Goffin E; Pirson Y; van Ypersele de Strihou C Clin Nephrol; 1994 May; 41(5):319. PubMed ID: 8050214 [No Abstract] [Full Text] [Related]
37. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
38. "A real world" dose comparison of lovastatin and pravastatin. Korman LB Am J Cardiol; 1994 Feb; 73(5):416-7; author reply 417-8. PubMed ID: 8109564 [No Abstract] [Full Text] [Related]
39. Pravastatin versus simvastatin--what happens in the real world? Levenstein S S Afr Med J; 1995 May; 85(5):388-91. PubMed ID: 7638696 [No Abstract] [Full Text] [Related]